APA-referens (7:e uppl.)

Wei, W., Xu, G., Gao, J., Wang, G., Wang, Y., Li, C., . . . Pan, X. (2025). Sacubitril/Valsartan partially alleviates myocardial infarction injury by activating the FGF21 signaling pathway via PPARs. Cardiovascular Diabetology, 24(1), 1. https://doi.org/10.1186/s12933-025-02627-6

Chicago-referens (17:e uppl.)

Wei, Wenjuan, et al. "Sacubitril/Valsartan Partially Alleviates Myocardial Infarction Injury by Activating the FGF21 Signaling Pathway via PPARs." Cardiovascular Diabetology 24, no. 1 (2025): 1. https://doi.org/10.1186/s12933-025-02627-6.

MLA-referens (9:e uppl.)

Wei, Wenjuan, et al. "Sacubitril/Valsartan Partially Alleviates Myocardial Infarction Injury by Activating the FGF21 Signaling Pathway via PPARs." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12933-025-02627-6.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.